Regency Capital Management Inc.\DE - ALLOVIR INC ownership

ALLOVIR INC's ticker is ALVR and the CUSIP is 019818103. A total of 92 filers reported holding ALLOVIR INC in Q3 2023. The put-call ratio across all filers is 2.33 and the average weighting 0.0%.

Quarter-by-quarter ownership
Regency Capital Management Inc.\DE ownership history of ALLOVIR INC
ValueSharesWeighting
Q3 2023$64,554
-74.7%
30,025
-60.0%
0.06%
-75.2%
Q2 2023$255,085
-13.7%
75,0250.0%0.22%
-38.0%
Q1 2023$295,599
-23.2%
75,0250.0%0.36%
-19.0%
Q4 2022$384,878
-35.0%
75,025
+0.0%
0.44%
-39.1%
Q3 2022$592,000
+102.7%
75,010
+0.0%
0.73%
+131.2%
Q2 2022$292,00075,0000.31%
Other shareholders
ALLOVIR INC shareholders Q3 2023
NameSharesValueWeighting ↓
Artal Group S.A. 5,577,167$44,004,0001.88%
GMT CAPITAL CORP 2,758,846$21,767,0001.35%
Regency Capital Management Inc.\DE 75,010$592,0000.73%
Redmile Group, LLC 1,907,969$15,054,0000.58%
Samsara BioCapital, LLC 82,336$650,0000.15%
Alkeon Capital Management 4,923,104$38,843,0000.13%
Woodline Partners LP 1,087,093$8,577,0000.12%
GSA CAPITAL PARTNERS LLP 77,625$612,0000.08%
CORNERCAP INVESTMENT COUNSEL INC 44,987$355,0000.07%
AMERICAN INTERNATIONAL GROUP, INC. 1,143,634$9,023,0000.07%
View complete list of ALLOVIR INC shareholders